Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
102 participants
INTERVENTIONAL
2021-08-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Developing Lung Cancer Screening in Hodgkin Lymphoma Survivors: a Qualitative Study
NCT04396119
Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks
NCT05902559
PD-L1 Expression in Lung Cancer
NCT04992715
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
NCT05699213
Single Pulmonary Nodule Investigation
NCT02013063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Invitation to have a low dose CT thorax
All participants are invited to undergo a low dose CT thorax
Low dose CT thorax
A low dose CT scan of the thorax to screen for lung cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low dose CT thorax
A low dose CT scan of the thorax to screen for lung cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 5 year or more survivor of HL
* Any of: a) treated with radiotherapy for HL with radiation dose to the lung b) an alkylating agent containing chemotherapy regimen known to increase lung cancer risk
* Living within approximately 40 miles of The Christie Hospital
Exclusion Criteria
* A current diagnosis of metastatic cancer
* Residents in nursing homes or housebound
* Had a CT scan of the thorax within the last 12 months
* Pregnant women
* Unable to provide consent
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Manchester
OTHER
The Christie NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Christie NHS Foundation Trust
Manchester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Broadbent R, Crosbie P, Armitage CJ, Taylor B, Tenant S, Mercer J, Radford J, Linton K. Pilot study of lung cancer screening for survivors of Hodgkin lymphoma. Haematologica. 2024 Oct 1;109(10):3305-3313. doi: 10.3324/haematol.2023.283287.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CFTSp204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.